MS Treatments Gilenya



Similar documents
MS Treatments Aubagio TM

Gilenya. Exceptional healthcare, personally delivered

Multiple sclerosis disease-modifying drugs second line treatments

Understanding your Tecfidera treatment

Understanding your Tecfidera treatment

Eastern Health MS Service. Tysabri Therapy. Information for People with MS and their Families

Disease Modifying Therapies for MS

AUBAGIO Conversation Starter

Oxford University Hospitals. NHS Trust. Department of Neurology Natalizumab (Tysabri) for Multiple Sclerosis. Information for patients

Living with MS. Multiple Sclerosis Society of Canada Call toll-free in Canada: Web site:

Disease Modifying Therapies for MS

Teriflunomide (Aubagio) 14mg once daily tablet

Information About Medicines for Multiple Sclerosis

Intravenous Methyl Prednisolone in Multiple Sclerosis

Leflunomide Leflunomide

Understanding. Multiple Sclerosis. Tim, diagnosed in 2004.

RISK EVALUATION AND MITIGATION STRATEGY (REMS)

Mitoxantrone. For multiple sclerosis. InfoNEURO INFORMATION FOR PATIENTS. Montreal Neurological Hospital

Which injectable medication should I take for relapsing-remitting multiple sclerosis?

Facts About Chickenpox and Shingles for Adults

MEDICATION GUIDE POMALYST (POM-uh-list) (pomalidomide) capsules. What is the most important information I should know about POMALYST?

Information about medicines for multiple sclerosis

CNS DEMYLINATING DISORDERS

Life with MS: Mastering Early Treatment

What is Multiple Sclerosis? Gener al information

Rituximab. Drug information Rituximab. This leaflet provides information on rituximab and will answer any questions you have about the treatment.

New treatments in MS What s here and what s nearly here

2 P age. Babies from Birth to Age 2

MEDICATION GUIDE SYLATRON (SY-LA-TRON) (Peginterferon alfa-2b)

IF YOU ARE RECEIVING TREATMENT WITH TYSABRI FOR RELAPSING-REMITTING MS (NATALIZUMAB)

Understanding How Existing and Emerging MS Therapies Work

Novartis Gilenya FDO Program Clinical Protocol and Highlights from Prescribing Information (PI)

Disease modifying drug therapy

QUESTIONS TO ASK MY DOCTOR

Liver Disease & Hepatitis Program Providers: Brian McMahon, MD, Steve Livingston, MD, Lisa Townshend, ANP. Primary Care Provider:

Stepping toward a different treatment option LEARN WHAT ACTHAR CAN DO FOR YOU

Presenting the SUTENT Patient Call Center.

Progress in MS: Current and Emerging Therapies

GILENYA Fingolimod hydrochloride Consumer Medicine Information (CMI)

Disease modifying drug therapy

Long term observational study for multiple sclerosis patients using fingolimod

Betaferon (interferon beta 1b)

Optic Neuritis. The optic nerve fibers are coated with myelin to help them conduct the electrical signals back to your brain.

Reintegration. Recovery. Medication-Assisted Treatment for Alcohol Dependence. Reintegration. Resilience

Managing the Symptoms of Multiple Sclerosis. Yolanda Harris, MSN, CRNP-AC CPODD Nurse Practitioner

Bayer Receives FDA Approval for BETACONNECT First and Only Electronic Autoinjector in Relapsing-Remitting Multiple Sclerosis (RRMS) Treatment

INITIATING ORAL AUBAGIO (teriflunomide) THERAPY

Learn about Diabetes. Your Guide to Diabetes: Type 1 and Type 2. You can learn how to take care of your diabetes.

FAQs about Warfarin (brand name Coumadin )

FastTest. You ve read the book now test yourself

The MS Disease- Modifying Medications GENERAL INFORMATION

Tuberculosis and You A Guide to Tuberculosis Treatment and Services

Section II When you are finished with this section, you will be able to: Define medication (p 2) Describe how medications work (p 3)

Many people with MS use some form of conventional medical treatment, and many people also use complementary and alternative medicine (CAM).

What You Need to Know About LEMTRADA (alemtuzumab) Treatment: A Patient Guide

Medicines To Treat Alcohol Use Disorder A Review of the Research for Adults

PHARMACIST DETACH HERE AND GIVE TO PATIENT

MEDICATION GUIDE mitoxantrone (mito-xan-trone) for injection concentrate

National Multiple Sclerosis Society. Disease Modification in Multiple Sclerosis. Current as of January 2, 2013

ORAL MEDICATIONS FOR MS! Gilenya and Aubagio

About MS. An introduction to. An introduction to multiple sclerosis for people who have recently been diagnosed. What is MS? Is it common?

Understanding Relapse in Multiple Sclerosis. A guide for people with MS and their families

Relapsing-remitting multiple sclerosis Ambulatory with or without aid

Lithium Therapy. Important information for patients COLLEGE CENTRE FOR QUALITY IMPROVEMENT

ORAL ANTICOAGULANTS - RIVAROXABAN (XARELTO) FOR ATRIAL FIBRILLATION

Temozolomide (oral) with concurrent radiotherapy to the brain

EXTAVIA (interferon beta-1b) Do not take EXTAVIA (interferon beta-1b) if you are allergic

Recognizing and Understanding Pain

The challenge of herpes

Key Facts about Influenza (Flu) & Flu Vaccine

The Family Library. Understanding Diabetes

MEDICATION GUIDE ACTOPLUS MET (ak-tō-plus-met) (pioglitazone hydrochloride and metformin hydrochloride) tablets

CBT IN THE CITY. adjusted to the news of being with MS? April Experts at your fingertips call now. Check out our new services in you local area

MEDICATION GUIDE WELLBUTRIN (WELL byu-trin) (bupropion hydrochloride) Tablets

Natalizumab (Tysabri)

The Nuts and Bolts of Multiple Sclerosis. Rebecca Milholland, M.D., Ph.D. Center for Neurosciences

Your Medicine: Play It Safe

Multiple Sclerosis (MS)

HOW TO CARE FOR A PATIENT WITH DIABETES

ORAL ANTICOAGULANTS - RIVAROXABAN (XARELTO) FOR DEEP VEIN THROMBOSIS (DVT)

SECTION 2. Section 2 Multiple Sclerosis (MS) Drug Coverage

Intestinal Permeability Leaky Gut Syndrome Protocol Dr. Kurt Woeller, D.O.

X-Plain Chemotherapy for Breast Cancer - Adriamycin, Cytoxan, and Tamoxifen Reference Summary

There is a risk of renal impairment in dehydrated children and adolescents.

Hepatitis A. What I need to know about. National Digestive Diseases Information Clearinghouse NATIONAL INSTITUTES OF HEALTH

TAKING CARE OF YOUR RHEUMATOID ARTHRITIS

MEDICATION GUIDE POTIGA (po-tee-ga) tablets, CV (ezogabine)

Share the important information in this Medication Guide with members of your household.

MEDICAL ASSISTANCE HANDBOOK PRIOR AUTHORIZATION OF PHARMACEUTICAL SERVICES. I. Requirements for Prior Authorization of Multiple Sclerosis Agents

what is warfarin? Treatment with Warfarin (Coumadin ) What is warfarin?

Vibramycin Capsules Doxycycline hyclate capsules USP. Vibra-Tabs Film Coated Tablets Doxycycline hyclate tablets USP

NeuroStar TMS Therapy Patient Guide for Treating Depression

EMD Serono Presents New Data on Rebif (Interferon beta-1a) and Multiple Sclerosis Pipeline at Joint ACTRIMS-ECTRIMS Meeting in Boston

12 Points of Tuberculosis (TB) Patient Education

Transcription:

1

MSology Essentials Series Gilenya (fingolimod) Developed by MSology with the invaluable assistance of multiple sclerosis nurse advisors: Trudy Campbell Dalhousie MS Research Unit, Capital Health, Halifax, Nova Scotia Sheryl Clarke MS Clinic, St. Michael s Hospital, Toronto, Ontario Colleen Harris MS Clinic, University of Calgary, Calgary, Alberta Gilenya and the Go Program are trademarks of Novartis

Why treat MS? Multiple sclerosis (MS) is believed to be caused by an abnormal immune response, which results in inflammation and tissue damage in the brain and spinal cord (together called the central nervous system, or CNS). This inflammation is the cause of MS symptoms, such as nerve tingling, muscle weakness, vision problems, balance difficulties and pain. New or worsening MS symptoms that last for more than a day or two are called relapses, and these generally indicate an inflammatory flare-up in the CNS. Relapse symptoms can persist for several weeks or months. Some relapses will resolve completely and some will not. As you experience more and more relapses, the body is unable to repair the damage to the brain and spinal cord, which typically leads to physical and mental impairments. That is why it is so important to treat MS to reduce inflammation and tissue damage, and reduce or delay disability. The medications prescribed are called disease-modifying therapies because they target the underlying MS disease process. They do not heal any tissue damage that has already occurred, but they may prevent further damage that will contribute to disability in the years ahead. MS medications do not treat specific symptoms, so you will not feel an improvement in the symptoms you are having. The main effects of therapy are to lessen the frequency and severity of relapses, and reduce the amount of inflammation in the brain and spinal cord. So treatment can be seen as an investment in your future lessening the often silent damage that is occurring now to prevent disabilities later on. 1

How does Gilenya work? Gilenya is an oral medication (capsule) used to treat relapsingremitting multiple sclerosis. In MS, specialized cells of the immune system become activated, enter the CNS and cause inflammation and tissue damage. Gilenya is able to lock away these immune cells in the lymph nodes so they aren t able to get into the CNS and cause damage. Clinical trials of Gilenya have shown that it reduces the rate of relapses, delays the onset of worsening disability, and suppresses inflammatory lesions in the brain in people with MS. Starting Gilenya Gilenya can lower your heart rate (pulse) and blood pressure when you start the medication, so you must be monitored when you take your first-dose. An appointment will be scheduled for you to go to a first-dose clinic. The first-dose observation takes 6 hours, so you ll need to book off time from work or school. When you arrive at the clinic, a nurse will ask you about your medical history and check your pulse and blood pressure. You must take the first dose of Gilenya at a clinic. This appointment takes at least 6 hours, so pack a lunch, and bring a book or some work to do to keep yourself busy. 2

An electrocardiogram (ECG) will be performed before and after you take your first dose, and your pulse and blood pressure will be checked periodically to ensure that everything is fine. You may need to stay longer if the test results are abnormal. It s best not to drive after your first dose, so arrange to have someone take you home. After taking the first dose, Gilenya can be taken at home like other medications. It s always important to take every dose of your medication as prescribed by your doctor so you receive the full benefit of treatment. This is especially important during the first 4 weeks of taking Gilenya: if you forget to take too many doses, you will need to go back to the clinic for another 6-hour appointment. This can be avoided simply by remembering to take your Gilenya once a day. 3

How do I take Gilenya? Dosing Gilenya must be taken once a day. 1x a day Gilenya is a capsule (0.5 mg), to be taken by mouth, without chewing. 0.5 mg Gilenya may be taken with or without food. Considerations Try to get into a routine of taking it at the same time each day, such as with breakfast or with your evening meal. If you forget to take a dose, do not double up the dose. Take your pill as soon as you remember (e.g. at lunch if you forgot at breakfast) or when you would normally take the next dose (e.g. at breakfast). 4

How do I know my treatment is working? During your course of treatment, your doctor will monitor your response to treatment with a variety of tests and procedures. These typically include neurological examinations to evaluate your nerve and muscle function, and magnetic resonance imaging (MRI) to assess the extent of inflammatory activity in your brain and spinal cord. Other tests and procedures may also be needed during your course of treatment. What if I have a relapse? A relapse is a new MS symptom you haven t had before, or a worsening of symptoms you ve previously experienced. The symptom persists for at least 24 hours. If you become overheated from exercise, a hot bath, a fever or infection your MS can worsen for a shorter period of time, but these symptoms are not a true relapse. You may have a relapse in the first few months after starting treatment, especially if your MS was very active before. This doesn t mean your medication is not working. You will only experience the full benefit of your MS medication after you ve been taking it continuously for a few months. It s important to inform your neurologist or MS nurse if you experience a relapse or any new or worsening symptoms that last more than 24 hours. 5

What are the possible side effects of Gilenya? Effects on the heart The first dose of Gilenya may slightly slow your heart rate (pulse) and lower blood pressure. These can occasionally cause symptoms such as dizziness or palpitations and, more rarely, effects on the heart rhythm. So your heart function will be monitored at the first-dose clinic. After a week or so, your body gets used to treatment and these heart effects typically go away. Gilenya can cause small increases in blood pressure later on, so your doctor will need to measure your blood pressure from time to time. Headaches If you experience headaches, take a pain reliever (e.g. Aspirin, Tylenol, ibuprofen) as you would for other headaches. Infections You may be more susceptible to infections during treatment. Contact your doctor or MS clinic nurse immediately if you think you have an infection. If you have not been exposed to chickenpox (varicella zoster virus) before, you ll need to be vaccinated before starting Gilenya. 6

Blurred vision Gilenya can cause swelling inside the eye and you will need to have an eye exam once you ve been on treatment for a few months. Eye symptoms may also be due to your MS, so contact your doctor or MS nurse if you are having any new or worsening vision problems. Effects on the liver Gilenya can have an effect on liver function so regular blood tests are needed. Report any symptoms of liver problems to your doctor immediately. These symptoms may include unexplained nausea/vomiting, abdominal pain, dark urine, yellowing of the skin (jaundice), loss of appetite and unusual tiredness. PML One case of PML (progressive multifocal leukoencephalopathy), a potentially fatal brain infection, has been reported with Gilenya. The risk of PML is considered to be very low. 7

Headaches Blurred vision Effects on the heart Effects on the liver Infections All medications have the potential to cause a variety of side effects. If you experience any new, unusual or worrisome symptoms while taking your medication, report them promptly to your doctor or MS nurse. Your MS nurse can often provide helpful advice to minimize any unwanted medication-related effects you may experience. 8

Tests and procedures During your course of treatment, your doctor will order a number of tests to ensure that your medication is not causing any unwanted effects. Some of the suggested tests are listed in the table. However, your neurologist and MS nurse will schedule which tests you will need and how often they should be done. Tests you may need during treatment with Gilenya* Test/procedure Reason How often Antibody test** (blood test) To see if you have had prior exposure to chickenpox Before starting Gilenya Vaccination** First dose monitoring: - Pulse - ECG (electrocardiogram) - Blood pressure Blood test To ensure immunity against chickenpox (varicella zoster virus) To monitor heart function To determine your complete blood cell count (CBC) The blood test will also be used to assess your liver function Before starting Gilenya During the first-dose clinic Blood pressure should be checked periodically according to your physician Before starting Gilenya Every 3-6 months in the first year of treatment Periodically according to your physician Eye exam To check for swelling in the eye After you ve been taking Gilenya for 3-4 months * Your neurologist or MS nurse will tell you more about the testing you ll need during treatment. Please ensure that you have all of the necessary tests at the recommended times. ** Not required if you have had chickenpox or were previously vaccinated 9

Pregnancy It s generally advisable to avoid taking medications during pregnancy because they may cause harm to the developing fetus. The best approach is to talk to your doctor or MS nurse before becoming pregnant so you can work out a schedule for stopping and re-starting your medication. Gilenya should not be taken during pregnancy or breastfeeding 10

Women should use a reliable method of contraception during treatment. Call your MS nurse if you are planning a pregnancy. Gilenya takes about 2 months to be eliminated from your body after you stop taking it, so it s best to wait until the drug is gone before trying to get pregnant. Gilenya should not be taken while you are breastfeeding. Contact your neurologist or MS nurse if you become pregnant while taking Gilenya. Once your baby is born and weaned, your MS nurse can schedule an appointment at a first-dose clinic so you can re-start Gilenya. Always use a reliable method of contraception while taking an MS medication. Talk to your doctor or MS nurse if you are planning a pregnancy in the next few months. 11

Other medications All medications have the potential to interact with other drugs you are taking. This includes other prescription medications, as well as non-prescription drugs and alternative/complementary therapies. Some of these medications can also worsen MS symptoms. Gilenya should not be taken at the same time as medications that lower heart rate (such as blood pressure medications) or affect heart rhythm (such as some antibiotics or antidepressants). Talk to a healthcare professional before taking any medication. Your doctor, MS nurse or pharmacist can advise you about interactions that may occur with Gilenya and the other medications you are taking. Other medical conditions Always ensure that your doctor is aware of any other medical conditions you may have. This includes high blood pressure, liver problems, diabetes, infections, or other illnesses. 12

Resources in your community Your neurologist or MS nurse can provide you with information on the Gilenya Go Program, which provides information and support for people taking Gilenya. Your local pharmacist can also provide important advice on your medication, how to take it, and what other medications (including non-prescription and alternative/complementary therapies) to avoid. 13

Contacting your MS nurse Contact your MS nurse if you have any questions or concerns about your medication. It is important to notify your doctor or MS nurse if you have any new, worrisome or unusual symptoms that may be related to your medication, or any worsening of your MS symptoms. Notify your doctor or MS nurse if you have any new symptoms 14

Notes 15

Notes 16

The MS Essentials series provides the latest information on multiple sclerosis medications, research, and lifestyle issues such as health, nutrition and exercise. All of the booklets are developed by Lind Publishing, publishers of MSology, to help people affected by MS remain active and informed. MS Essentials is provided free of charge. The full series of publications is available for download on http://www.msology.com. The information reflects use of the medication in Canada; use may vary in other countries. MSology does not approve, endorse or recommend any specific product or therapy. Contact your healthcare providers before you start treatment, alter the dose, interrupt or discontinue your therapy. For full information about a specific medication, consult the prescribing information or package insert provided by the manufacturer for your country.

This booklet is produced by: Lind Publishing Inc. 460-376 avenue Victoria Westmount, QC H3Z 1C3 Canada Telephone: +1 (514) 482-9096 Fax: +1 (514) 482-8254 Email: Info@lindpublishing.com For more multiple sclerosis information, visit www.msology.com